Detalles de la búsqueda
1.
Effect of treatment dose reductions in the setting of hand-foot syndrome on survival outcomes in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor receptor inhibitors.
J Oncol Pharm Pract
; 24(3): 190-197, 2018 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-28436250
2.
Targeting Bacteroides in Stool Microbiome and Response to Treatment With First-Line VEGF Tyrosine Kinase Inhibitors in Metastatic Renal-Cell Carcinoma.
Clin Genitourin Cancer
; 16(5): 365-368, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29858123
3.
A phase I clinical trial of the effect of belinostat on the pharmacokinetics and pharmacodynamics of warfarin.
Cancer Chemother Pharmacol
; 77(2): 299-308, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26719074
4.
A phase I study to determine the pharmacokinetics and urinary excretion of belinostat and metabolites in patients with advanced solid tumors.
Cancer Chemother Pharmacol
; 78(5): 1059-1071, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27744565
5.
Correlation of degree of hypothyroidism with survival outcomes in patients with metastatic renal cell carcinoma receiving vascular endothelial growth factor receptor tyrosine kinase inhibitors.
Clin Genitourin Cancer
; 13(3): e131-7, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25497584
Resultados
1 -
5
de 5
1
Próxima >
>>